Degeneration
9
1
1
2
Key Insights
Highlights
Success Rate
40% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 100/100
33.3%
3 terminated out of 9 trials
40.0%
-46.5% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 2 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (9)
Vertebropexy - Randomized-controlled Trial
Offsetting Hippocampal Degeneration in m-sTBI
Effects of Ping-Shuai-Gong and Arm-Swing-Exercise
A Comparison of PRP Treatment to the IA vs. IA and EA Environments in Patients Diagnosed With Hip Osteoarthritis
Cross-linking of Corneal Collagen (CXL) With Ultraviolet-A in Asymmetric Corneas
Collagen Crosslinking With Ultraviolet-A in Asymmetric Corneas (2)
Collagen Crosslinking With Ultraviolet-A in Asymmetric Corneas
Prospective Clinical Evaluation of the New Aegis Plate for Anterior Interbody Fusions
Symptoms of Degeneration in Shoulder of Wheelchair-users